HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Cervical Biopsy

A cervical biopsy is a medical procedure that involves the removal of a small tissue sample from the cervix for further examination. This diagnostic test is typically recommended when there are abnormalities detected during a routine Pap smear or other cervical screening tests. During the biopsy, a healthcare provider will use specialized instruments to collect a tiny piece of tissue from the cervix. This sample is then sent to a laboratory for analysis by a pathologist. The primary purpose of a cervical biopsy is to identify and assess any abnormal changes in the cervical cells, which could indicate precancerous or cancerous conditions. There are different types of cervical biopsies, including colposcopy-guided biopsy, endocervical curettage, and cone biopsy. The choice of biopsy method depends on the specific circumstances and the nature of the abnormalities observed. Cervical biopsies play a crucial role in the early detection of cervical cancer, allowing healthcare professionals to initiate appropriate interventions and treatments promptly. It is a relatively quick and outpatient procedure, and most women experience minimal discomfort. After the biopsy, some individuals may experience mild cramping or spotting, but these symptoms typically subside within a short period. The results of the biopsy provide valuable information that guides healthcare professionals in determining the most suitable course of action for the patient, whether it involves monitoring, additional testing, or necessary medical interventions to address any identified issues. Regular cervical screenings and timely biopsies contribute significantly to the overall prevention and management of cervical health issues.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp